Analysis of Innovations in Monitoring Adverse Drug Reaction and Application

Abstract

Objective To systematically study foreign adverse drug reaction monitoring technologies and applications to extract valuable experience, and provide reference for promoting its application in China. Methods Literature research, comparative research and other methods were used to investigate foreign adverse drug reaction (ADR) monitoring technologies and applications such as passive reporting systems, active monitoring systems, electronic health records and real-world data, and analyze the problems in the application of the above technologies in China. Results and Conclusion At present, China is relatively mature in the application of ADR passive reporting system, but there are some problems in the application of ADR active monitoring system, electronic health records and real-world data. In the future, we should improve the application of adverse drug reaction active monitoring system, establish close cooperation with universities, research institutes and other institutions to improve the evaluation of adverse drug reactions. Besides, we should promote the construction of the Chinese medical language processing system and strengthen the understanding of real-world data. This will improve the level of monitoring adverse drug reactions in China and promote rational drug use.

Keywords

adverse drug reaction / active monitoring / technical system / real-world data

References

[1] Ministry of Health. Administrative Measures for Reporting and Monitoring of Adverse Drug Reactions[S]. Order No. 81 of the Ministry of Health, 2011.

[2] Chen Yan, Guo Jianfei, Jiang Dongming. Database mining and exploration and analysis of adverse drug reaction signals (part II)[J]. Journal of Pharmacoepidemiology, 2006, 15 (2): 104-107.

[3] Perlman A, Heyman SN, Matok I. Acute renal failure with sodium-glucose-cotransporter-2 inhibitors: Analysis of the FDA adverse event report system database[J]. Nutr Metab Cardiovasc Dis, 2017, 27 (12): 1108-1113.

[4] Aggarwal N. Local anesthetics systemic toxicity association with exparel (bupivacaine liposome) - a pharmacovigilance evaluation[J]. Expert Opin Drug Saf, 2018, 17 (6): 581-587.

[5] Schwan S, Sundstrom A, Stjernberg EA. Signal for an abuse liability for pregabalin - results from the Swedish spontaneous adverse drug reaction reporting system[J]. European Journal of Clinical Pharmacology, 2010, 66 (9): 947-953.

[6] Classen DC, Pestotnik SL, Evans RS, et al. Computerized surveillance of adverse drug events in hospital patients[J]. Qual Saf Health Care, 2005, 14 (3): 221-226.

[7] Almeida SMD, Romualdo A, Ferraresi ADA, et al. Use of a trigger tool to detect adverse drug reactions in an emergency department[J]. BMC Pharmacol Toxicol, 2017, 18: 71.

[8] Zhao Junke, Zhang Zhenyu, Cai Kaiyu. Medical entity recognition and label extraction based on natural language processing[J]. Computer Technology and Development, 2019 (9): 18-23.

[9] Wang Yuanhang, Liu Fuyang. Research progress of automatic monitoring technology for adverse drug reactions[J]. China Pharmacovigilance, 2010, 7 (1): 41-44.

[10] Tan Zhiyuan, Zhao Rongsheng. Research progress on the application of artificial intelligence technology in monitoring and reporting of adverse drug reactions[J]. Journal of Clinical Drug Therapy, 2019, 17 (2): 23-27.

[11] Yang Liu, Wang Yu. A review of various cross-validation estimation methods for generalization error[J]. Computer Application Research, 2015, 32 (5): 1287-1290+1297.

[12] Abeed S, Rachel G, Azadeh N, et al. Utilizing social media data for pharmacovigilance[J]. Journal of Biomedical Informatics, 2015, 54: 202-212.

[13] Smith K, Golder S, Sarker A, et al. Methods to compare adverse events in twitter to FAERS, drug information databases, and systematic reviews: Proof of concept with adalimumab[J]. Drug Safety, 2018, 41 (12): 117-120.